JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yao, L.
Right arrow Articles by Diamond, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, L.
Right arrow Articles by Diamond, I.

Vol. 298, Issue 2, 833-839, August 2001

Dopamine D2 Receptor Inhibition of Adenylyl Cyclase Is Abolished by Acute Ethanol but Restored after Chronic Ethanol Exposure (Tolerance)

Lina Yao , Kiyofumi Asai1, Zhan Jiang, Akira Ishii2, Peidong Fan, Adrienne S. Gordon and Ivan Diamond

Ernest Gallo Clinic and Research Center (L.Y., Z.J., P.F., A.S.G., I.D.), Departments of Neurology (L.Y., A.S.G., I.D.), Cellular and Molecular Pharmacology (A.S.G., I.D.), and Neuroscience Graduate Program and Center for the Neurobiology of Addiction (A.S.G., I.D.), University of California, San Francisco, California

Dopamine D2 (D2) receptors seem to mediate reinforcing responses to addicting drugs. A stably transfected NG108-15 cell line expressing the long form of the rat brain D2 receptor (D2L) was used to determine how ethanol modifies D2 receptor coupling to adenylyl cyclase. Activation of D2L receptors by the D2 receptor-specific agonist R-(-)-2,10,11-trihydroxy-N-propylnorapomorphine hydrobromide (NPA) inhibits both basal and receptor-stimulated cAMP production in these cells. Ethanol added acutely prevents D2L receptor inhibition of cAMP production. After chronic exposure to ethanol, however, D2L receptor coupling to adenylyl cyclase becomes tolerant to rechallenge with ethanol, i.e., ethanol no longer inhibits D2L receptor coupling and NPA inhibition of cAMP production is restored. Acute ethanol does not change NPA binding to D2 receptor in cell membranes but abolishes guanosine-5'-O-(3-thio)triphosphate induction of a lower-affinity state; chronic ethanol is without effect. The protein kinase A (PKA) inhibitor adenosine 3',5' cyclic monophosphorothioate, Rp-isomer, prevents acute ethanol inhibition of D2L receptor coupling. In contrast, the PKA activator adenosine 3',5' cyclic monophosphorothioate, Sp-isomer, reverses chronic ethanol-induced tolerance of D2L receptor coupling, restoring coupling to an ethanol-sensitive state. These results suggest that D2L receptor coupling to adenylyl cyclase via Gi develops tolerance to ethanol inhibition, which appears to be influenced by PKA activity.


1 Current address: Department of Bioregulation, Research Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan.

2 Current address: Department of Legal Medicine and Bioethics, Nagoya University Postgraduate School of Medicine, G5 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.


0022-3565/01/2982-0833$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. J. Oldenburg, T. A. Wyatt, P. H. Factor, and J. H. Sisson
Alcohol feeding blocks methacholine-induced airway responsiveness in mice
Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L109 - L114.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.